Mayo Clinic Proceedings Publishes ISSWSH's Process of Care for the Identification of Sexual Concerns and Problems in Women

Sexual problems are common in women of all ages. Despite their frequency and impact, female sexual dysfunctions (FSDs) are often unrecognized and untreated in clinical settings. This POC describes core and advanced competencies in FSD for clinicians who are not sexual medicine specialists and serve as caregivers of women and, therefore, is useful for clinicians with any level of competence in sexual medicine. The goal of the POC is to provide guidance to clinicians regarding screening, education, management, and referral for women with sexual problems.

This Open Access article is now available: Here.

ISSWSH CME Forum at ACOG

ISSWSH CME Forum at the ACOG Annual Clinical and Scientific Meeting
Hypoactive Sexual Desire Disorder: Who, What, When, Where and Why?
Join us on Sunday, May 5, 2019 from 6:15 - 7:45 am in Room 101 BC - Music City Center in Nashville, TN to learn how to diagnose and treat women with HSDD. Breakfast will be available.

Agenda:
6:15 - 6:20 am Welcome
6:20 - 6:30 am Introduction - James A. Simon, MD, CCD, NCMP, IF, FACOG
6:30 - 6:45 am Central mechanisms of HSDD: What are they? - James G. Pfaus, PhD, IF
6:45 - 7:00 am Treatment options for HSDD: Where is the evidence? When should treatment be offered? - Brooke Faught DNP, WHNP-BC, NCMP, IF
7:00 - 7:15 am Who has HSDD in your practice? Why should she be treated? - Lauren F. Streicher, MD
7:15 - 7:30 am What's on the horizon? - James A. Simon, MD, CCD, NCMP, IF, FACOG
7:30 - 7:45 am Questions & Answers

Take a look at works recently published by ISSWSH

Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society)

Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions—Part III

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health